Variant report

Variant	nsv481773
Chromosome Location	chr6:162375136-162610247
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:23)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
2	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
3	chr6:162525404..162526979-chr6:162529518..162531928,2	MCF-7	breast:
4	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
5	chr6:162525404..162526979-chr6:162529518..162531928,2	MCF-7	breast:
6	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
7	chr3:66689243..66689865-chr6:162514238..162514739,2	MCF-7	breast:
8	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
9	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
10	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
11	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
12	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
13	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
14	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
15	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
16	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
17	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
18	chr6:162500411..162502828-chr6:162504694..162507642,2	K562	blood:
19	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
20	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
21	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
22	chr6:162500411..162502828-chr6:162504694..162507642,2	K562	blood:
23	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:

No data

Extended variants
information (count: 7868 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:7868 , 50 per page) page: 1 2 3 4 5 6 7 ... 158

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs112801879	chr6:162375174-162375175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs543195501	chr6:162375175-162375176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs563180765	chr6:162375198-162375199	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs573593387	chr6:162375213-162375214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs75853104	chr6:162375215-162375216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs78063699	chr6:162375254-162375255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs1790013	chr6:162375278-162375279	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs200326911	chr6:162375317-162375318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs1790011	chr6:162375318-162375319	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs564401195	chr6:162375333-162375334	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs533509048	chr6:162375339-162375340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs550393701	chr6:162375341-162375342	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs570268172	chr6:162375412-162375413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs371495378	chr6:162375432-162375433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs529572678	chr6:162375486-162375487	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs549715546	chr6:162375525-162375526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs60894483	chr6:162375569-162375570	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs544249286	chr6:162375570-162375571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs186688537	chr6:162375603-162375604	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs534303329	chr6:162375619-162375620	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs146680712	chr6:162375728-162375729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs60022612	chr6:162375743-162375744	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs375872119	chr6:162375748-162375749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs371311490	chr6:162375761-162375762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs569804315	chr6:162375797-162375798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs534512983	chr6:162375803-162375804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs550818597	chr6:162375867-162375868	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs368011461	chr6:162375868-162375869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs1784597	chr6:162375909-162375910	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs556690265	chr6:162375919-162375920	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs191100963	chr6:162375993-162375994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs116801173	chr6:162376007-162376008	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs553013215	chr6:162376050-162376051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs573119625	chr6:162376097-162376098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs541050437	chr6:162376098-162376099	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs1784596	chr6:162376101-162376102	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs533419621	chr6:162376114-162376115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs78056106	chr6:162376131-162376132	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs543944547	chr6:162376182-162376183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs1790010	chr6:162376194-162376195	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs534960966	chr6:162376224-162376225	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs375205943	chr6:162376280-162376281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs150045884	chr6:162376297-162376298	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs1790009	chr6:162376359-162376360	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs566229308	chr6:162376364-162376365	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs578093932	chr6:162376423-162376424	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs574860005	chr6:162376464-162376465	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs184154564	chr6:162376466-162376467	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs373588653	chr6:162376473-162376474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs189803735	chr6:162376488-162376489	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Bipolar disorder	19114987	CNVD
early-passage human iPS cells	21368824	CNVD
Parkinson disease	21829596	CNVD
Schizophrenia	23813976	CNVD
Gastric cancer	22315472	CNVD
Autism	19404257	CNVD

Chromatin state (count:625 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162364800-162377000	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr6:162368000-162377200	Weak transcription	Fetal Brain Male	brain
3	chr6:162371000-162384000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr6:162372400-162376000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
5	chr6:162372600-162375200	Weak transcription	Right Atrium	heart
6	chr6:162372600-162377000	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr6:162372600-162377000	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr6:162372600-162377000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
9	chr6:162372600-162377000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
10	chr6:162372600-162377000	Weak transcription	Cortex derived primary cultured neurospheres	brain
11	chr6:162372600-162377200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
12	chr6:162374600-162376400	Enhancers	Left Ventricle	heart
13	chr6:162374800-162375400	Enhancers	HSMMtube	muscle
14	chr6:162374800-162380400	Weak transcription	Gastric	stomach
15	chr6:162375000-162375200	Enhancers	Pancreas	Pancrea
16	chr6:162375200-162375600	Enhancers	Fetal Brain Female	brain
17	chr6:162375200-162376200	Enhancers	Right Atrium	heart
18	chr6:162375200-162377600	Enhancers	Ovary	ovary
19	chr6:162375200-162384800	Weak transcription	Pancreas	Pancrea
20	chr6:162375800-162376400	Enhancers	Right Ventricle	heart
21	chr6:162376000-162376200	Enhancers	Aorta	Aorta
22	chr6:162376000-162377600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr6:162376200-162380200	Weak transcription	Aorta	Aorta
24	chr6:162376200-162384200	Weak transcription	Right Atrium	heart
25	chr6:162376400-162379400	Weak transcription	Left Ventricle	heart
26	chr6:162376800-162377000	Weak transcription	HUES6 Cell Line	embryonic stem cell
27	chr6:162377000-162377400	Enhancers	H9 Cell Line	embryonic stem cell
28	chr6:162377000-162377400	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr6:162377000-162377400	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr6:162377000-162377600	Enhancers	HUES6 Cell Line	embryonic stem cell
31	chr6:162377000-162377600	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr6:162377000-162377600	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr6:162377000-162377600	Enhancers	Cortex derived primary cultured neurospheres	brain
34	chr6:162377200-162377400	Enhancers	Fetal Brain Male	brain
35	chr6:162377200-162377600	Enhancers	iPS-15b Cell Line	embryonic stem cell
36	chr6:162377200-162384000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
37	chr6:162377600-162384200	Weak transcription	Cortex derived primary cultured neurospheres	brain
38	chr6:162377600-162384400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
39	chr6:162382600-162382800	ZNF genes & repeats	Aorta	Aorta
40	chr6:162382800-162383000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr6:162382800-162383400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr6:162382800-162396600	Weak transcription	Aorta	Aorta
43	chr6:162383200-162384400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr6:162383400-162384400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr6:162384000-162384400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr6:162384000-162386000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr6:162384200-162384400	Enhancers	Right Atrium	heart
48	chr6:162384200-162384600	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr6:162384200-162384800	Enhancers	HUES48 Cell Line	embryonic stem cell
50	chr6:162384200-162385000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links